These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33397387)

  • 21. Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
    Sholukh AM; Fiore-Gartland A; Ford ES; Miner MD; Hou YJ; Tse LV; Kaiser H; Zhu H; Lu J; Madarampalli B; Park A; Lempp FA; St Germain R; Bossard EL; Kee JJ; Diem K; Stuart AB; Rupert PB; Brock C; Buerger M; Doll MK; Randhawa AK; Stamatatos L; Strong RK; McLaughlin C; Huang ML; Jerome KR; Baric RS; Montefiori D; Corey L
    J Clin Microbiol; 2021 Sep; 59(10):e0052721. PubMed ID: 34288726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum.
    Abidi SH; Imtiaz K; Kanji A; Qaiser S; Khan E; Iqbal K; Veldhoen M; Ghias K; Simas JP; Hasan Z
    PLoS One; 2021; 16(12):e0259551. PubMed ID: 34890401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity.
    Dolscheid-Pommerich R; Bartok E; Renn M; Kümmerer BM; Schulte B; Schmithausen RM; Stoffel-Wagner B; Streeck H; Saschenbrecker S; Steinhagen K; Hartmann G
    J Med Virol; 2022 Jan; 94(1):388-392. PubMed ID: 34415572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.
    Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Teloni R; De Angelis ML; Gallinaro A; Pirillo MF; Borghi M; Canitano A; Michelini Z; Baggieri M; Marchi A; Bucci P; McKay PF; Acchioni C; Sandini S; Sgarbanti M; Tosini F; Di Virgilio A; Venturi G; Marino F; Esposito V; Di Bonito P; Magurano F; Cara A; Negri D; Nisini R
    Front Immunol; 2021; 12():750386. PubMed ID: 34764961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay.
    Nam M; Seo JD; Moon HW; Kim H; Hur M; Yun YM
    Microbiol Spectr; 2021 Dec; 9(3):e0120221. PubMed ID: 34817223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study.
    Griffante G; Chandel S; Ferrante D; Caneparo V; Capello D; Bettio V; Borgogna C; Aleni C; Esposito S; Sarro A; Vasile A; Comba M; Testa T; Cotrupi G; De Andrea M; Bortoluzzi S; Gariglio M
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semiquantitative Paper-Based Microfluidic Surrogate Virus Neutralization Test for SARS-CoV-2 Neutralizing Antibodies.
    Mahmud MA; Xu LH; Usatinsky A; Dos Santos CC; Little DJ; Tsai SSH; Rackus DG
    Anal Chem; 2024 Jul; 96(29):11751-11759. PubMed ID: 38980117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter.
    Tsai WY; Ching LL; Hsieh SC; Melish ME; Nerurkar VR; Wang WK
    Emerg Microbes Infect; 2021 Dec; 10(1):894-904. PubMed ID: 33929934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Ferrer J; Forqué L; Costa R; de la Asunción CS; Huntley D; Gozalbo-Rovira R; Buesa J; Giménez E; Rodríguez-Díaz J; Geller R; Navarro D
    J Med Virol; 2021 Apr; 93(4):2301-2306. PubMed ID: 33236799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Hu Z; López-Muñoz AD; Kosik I; Li T; Callahan V; Brooks K; Yee DS; Holly J; Santos JJS; Castro Brant A; Johnson RF; Takeda K; Zheng ZM; Brenchley JM; Yewdell JW; Fox JM
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2310421121. PubMed ID: 38976733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays.
    Perkmann T; Perkmann-Nagele N; Koller T; Mucher P; Radakovics A; Marculescu R; Wolzt M; Wagner OF; Binder CJ; Haslacher H
    Microbiol Spectr; 2021 Sep; 9(1):e0024721. PubMed ID: 34190591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples.
    Meyrath M; Szpakowska M; Plesseria JM; Domingues O; Langlet J; Weber B; Krüger R; Ollert M; Chevigné A;
    Methods Enzymol; 2022; 675():351-381. PubMed ID: 36220277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect.
    Cin D; Soguksu P; Oren MM; Ozgulnar N; Agacfidan A; Mese S
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
    Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
    Klingler J; Weiss S; Itri V; Liu X; Oguntuyo KY; Stevens C; Ikegame S; Hung CT; Enyindah-Asonye G; Amanat F; Baine I; Arinsburg S; Bandres JC; Kojic EM; Stoever J; Jurczyszak D; Bermudez-Gonzalez M; Nádas A; Liu S; Lee B; Zolla-Pazner S; Hioe CE
    J Infect Dis; 2021 Mar; 223(6):957-970. PubMed ID: 33367897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
    Tso FY; Lidenge SJ; Poppe LK; Peña PB; Privatt SR; Bennett SJ; Ngowi JR; Mwaiselage J; Belshan M; Siedlik JA; Raine MA; Ochoa JB; Garcia-Diaz J; Nossaman B; Buckner L; Roberts WM; Dean MJ; Ochoa AC; West JT; Wood C
    PLoS One; 2021; 16(3):e0247640. PubMed ID: 33661923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples.
    Sancilio AE; D'Aquila RT; McNally EM; Velez MP; Ison MG; Demonbreun AR; McDade TW
    Sci Rep; 2021 Jul; 11(1):15321. PubMed ID: 34321523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.